Products

Stealth AXiS Cranial clinical application
Medtronic
Neurology AI
Stealth AXiS Cranial is an AI-enabled surgical navigation application by Medtronic Navigation, Inc. designed to enhance precision and visualization during cranial procedures.
Guardian Connect
Medtronic
Endocrinology & Metabolic AI
The Medtronic Guardian Connect system is a continuous glucose monitoring (CGM) system that provides real-time glucose level monitoring and alerts on mobile devices, with AI capabilities for predicting blood glucose changes.
Reveal LINQ Insertable Cardiac Monitor
Medtronic
Cardiology AI
The Medtronic LINQ II™ Insertable Cardiac Monitor (ICM) with AccuRhythm™ AI algorithms provides long-term, accurate heart monitoring by using deep learning AI to reduce false alerts and enhance diagnostic yield for conditions like atrial fibrillation and syncope.

See all 5 products →

About Medtronic

Medtronic is a global leader in medical technology, services, and solutions, dedicated to alleviating pain, restoring health, and extending life for millions worldwide. Founded in 1949, the company develops and manufactures a broad portfolio of healthcare technologies and therapies, addressing over 70 health conditions across its key business segments: Cardiovascular, Neuroscience, Medical Surgical, and Diabetes.

For physicians, Medtronic offers a comprehensive array of advanced medical devices and integrated solutions designed to enhance clinical outcomes and operational efficiency. The company is actively integrating artificial intelligence (AI) into its offerings, focusing on areas such as predictive analytics for earlier disease detection, workflow automation to streamline clinical processes, and personalized care tools to tailor treatments to individual patient needs.

Medtronic’s commitment to responsible innovation is guided by its ‘AI Compass,’ an ethical framework ensuring that AI-enabled technologies are developed and deployed with patient health outcomes, safety, and equity in mind. This includes leveraging AI to improve heart monitoring by filtering out false alerts, supporting complex surgeries through advanced simulations, and enhancing colonoscopy procedures for better lesion identification.

Focus Areas

Medical devices healthcare technologies therapies chronic disease management diabetes management cardiac care minimally invasive therapies restorative therapies surgical technologies AI-powered diagnostics robotic-assisted surgery surgical video analytics remote monitoring neurostimulation

Business Intelligence

PartnershipsVizient, DaVita Inc., GE Healthcare, CathWorks, Cydar Medical, Merit Medical Systems, American Society for Gastrointestinal Endoscopy, Amazon Web Services
AcquisitionsScientia Vascular (March 2026), CathWorks (Feb 2026), EOFlow (May 2023), Affera, Inc. (Jan 2022), Intersect ENT (Aug 2021), Companion Medical (Aug 2020), Medicrea (Jul 2020), Digital Surgery (Feb 2020), Stimgenics, LLC (Jan 2020), Mazor Robotics (Sept 2018)
TechnologyCloud-native, AI operating system, data analytics, machine learning, sensors, AI Compass framework for ethical AI development, Touch Surgery™ Enterprise (AI-powered video management and analytics platform), AccuRhythm AI, GI Genius™ intelligent endoscopy module, AiBLE™ system for robotic-assisted surgeries, AI-based automatic tractography
FDA Clearances3 (AI-related products listed: GI Genius™ intelligent endoscopy module, AccuRhythm™ AI algorithms for LINQ II™ ICM, Stealth AXiS™ surgical system) cleared products (estimated)

What Physicians Need to Know

AI-Powered Diagnostics
Medtronic leverages AI for enhanced diagnostic accuracy, notably with GI Geniusu2122 for real-time colorectal polyp detection (reducing missed polyps by up to 50%) and AccuRhythmu2122 AI for cardiac monitoring, which significantly reduces false alerts (up to 89.5% for AF and 80.2% for pauses) in insertable cardiac monitors.
Robotic-Assisted Surgery
The Hugou2122 Robotic-Assisted Surgery (RAS) system offers a flexible, modular platform for minimally invasive procedures, including urologic and gynecologic surgeries. It's complemented by the Touch Surgeryu2122 Ecosystem, an AI-powered solution that provides surgical video analysis, performance insights, and training simulations, supporting continuous improvement for surgeons.
Chronic Disease Management
Medtronic offers advanced solutions for chronic conditions, including the MiniMedu2122 780G hybrid closed-loop insulin delivery system for diabetes management, which automatically adjusts insulin delivery. For chronic pain and movement disorders, neurostimulation therapies like Deep Brain Stimulation (DBS) and Spinal Cord Stimulation (SCS) provide personalized relief.
Cardiac Care & Remote Monitoring
A leader in cardiac rhythm management, Medtronic provides pacemakers, defibrillators, and insertable cardiac monitors. Their comprehensive remote monitoring solutions, such as MyCareLinku2122 and MyCareLink Heartu2122 mobile app, allow implanted cardiac devices to communicate with clinics, enabling early detection of issues and reducing the need for in-person visits. HealthCastu2122 Vital Syncu2122 extends continuous monitoring to at-risk patients in various settings.
Minimally Invasive & Restorative Therapies
Beyond robotics, Medtronic specializes in a broad range of minimally invasive therapies, including advanced surgical tools, PillCamu2122 capsule endoscopy, and renal denervation for hypertension. Restorative therapies encompass solutions for spine, brain (e.g., MRI-guided laser ablation), and pelvic health.
Surgical Video Analytics & Training
The Touch Surgeryu2122 Ecosystem provides AI-powered surgical video analytics, offering post-operative insights into procedure metrics, anatomy identification, and instrument use. This platform also includes interactive simulations and live streaming capabilities for surgical training and continuous skill refinement.
Integrated Healthcare Solutions
Medtronic is transitioning from a hardware manufacturer to a provider of 'Intelligent Healthcare Solutions' by integrating AI, robotics, sensors, and data analytics across its cardiovascular, neuroscience, medical surgical, and diabetes portfolios. This approach aims to deliver personalized, efficient, and accessible care.
Physician Tip

For physicians, Medtronic stands out by offering a comprehensive ecosystem of advanced medical technologies designed to enhance clinical decision-making, improve surgical precision, and streamline workflows. Their AI-powered diagnostics (e.g., GI Geniusu2122, AccuRhythmu2122 AI) provide more accurate and timely insights, reducing false positives and allowing for earlier intervention. The Hugou2122 RAS system and Touch Surgeryu2122 Ecosystem empower surgeons with robotic assistance, real-time data, and post-operative analytics for continuous skill improvement and better patient outcomes. Furthermore, Medtronic's extensive remote monitoring capabilities for cardiac devices and chronic conditions enable continuous patient oversight, reducing the burden of in-person visits and facilitating proactive care management. The focus on integrating these technologies with EMRs aims to reduce manual charting and transcription errors, freeing up valuable clinician time to focus on patient care. Medtronic's commitment to R&D and a broad, diversified portfolio ensures access to cutting-edge, evidence-based therapies across numerous specialties.

Medtronic prioritizes seamless integration of its patient monitoring technologies with existing Electronic Medical Record (EMR) systems, Active Directory, and alarm annunciation systems. Services like 'EMR Connect' and 'HealthCastu2122 services' are designed to facilitate device delivery, implementation, and EMR connectivity. This robust integration aims to reduce manual charting, eliminate transcription errors, standardize clinical workflows, and provide fast, easy access to patient data, ultimately supporting effective decision-making and optimizing reimbursement administration.

Products by Medtronic

5 products in the directory

Stealth AXiS Cranial clinical application
Medtronic
Neurology AI
Stealth AXiS Cranial is an AI-enabled surgical navigation application by Medtronic Navigation, Inc. designed to enhance precision and visualization during cranial procedures.
Guardian Connect
Medtronic
Endocrinology & Metabolic AI
The Medtronic Guardian Connect system is a continuous glucose monitoring (CGM) system that provides real-time glucose level monitoring and alerts on mobile devices, with AI capabilities for predicting blood glucose changes.
Reveal LINQ Insertable Cardiac Monitor
Medtronic
Cardiology AI
The Medtronic LINQ II™ Insertable Cardiac Monitor (ICM) with AccuRhythm™ AI algorithms provides long-term, accurate heart monitoring by using deep learning AI to reduce false alerts and enhance diagnostic yield for conditions like atrial fibrillation and syncope.
LINQ II Insertable Cardiac Monitor
Medtronic
Cardiology AI
The Medtronic LINQ II is an advanced, AI-powered insertable cardiac monitor providing long-term, continuous heart rhythm monitoring with remote programming and enhanced accuracy for diagnosing arrhythmias.
Reveal LINQ
Medtronic
Cardiology AI
Medtronic Reveal LINQ is a tiny, implantable cardiac monitor that continuously records ECG for up to three years, utilizing AccuRhythm™ AI algorithms to accurately detect and diagnose cardiac arrhythmias, including atrial fibrillation, cryptogenic stroke, and unexplained syncope.

What the Web Says

Medtronic receives mixed reviews, with employees often praising the company's mission, culture, and benefits, but expressing significant concerns about frequent layoffs and management. Product reviews, particularly for their diabetes management devices, highlight issues with reliability, outdated technology, and poor customer service. While some users find their products effective, many report a decline in quality and a preference for competitors.

Overall: Mixed

Strengths

  • Strong company mission and patient-first culture.
  • Good benefits package, including health insurance, pension, and PTO.
  • Opportunities for growth and learning in some roles.
  • Supportive and inclusive work environment with great colleagues.
  • Competitive mentality and challenging work.
  • Good pay for certain positions, especially compared to other jobs not requiring post-secondary education.

Limitations

  • Frequent and arbitrary layoffs, leading to job insecurity and stress.
  • Decline in product quality and reliability, particularly for insulin pumps and CGM sensors.
  • Outdated technology in some product lines compared to competitors.
  • Poor customer service, with reports of unhelpful and gaslighting interactions.
  • Management issues, including lack of recognition, unrealistic expectations, and poor communication.
  • Repetitive and mind-numbing work in some manufacturing roles.

Based on reviews from: Reddit, Indeed.com, Trustpilot, Payscale, FlexJobs

Last updated: 2026-07-18

Videos

News, demos, and interviews about Medtronic.

Loading videos...

Videos load interactively. If none appear, search YouTube for Medtronic →

View all on YouTube

Press & Coverage

Medtronic Newsroom
Medtronic completes acquisition of SPR, expanding patient access to minimally invasive, non-opioid treatment of chronic and acute pain
Medtronic announced the completion of its acquisition of SPR Therapeutics, a company specializing in short-term peripheral nerve stimulation therapies for pain management. The acquisition, valued at $650 million, aims to broaden Medtronic's pain therapy portfolio.
2026-07
Medtronic Newsroom
Medtronic completes acquisition of Scientia Vascular, seamlessly integrating access and therapeutic portfolios for neurovascular care
Medtronic has completed the acquisition of Scientia Vascular, integrating its access and therapeutic portfolios to enhance neurovascular care. This move aims to deliver simplicity and support physicians across the full procedural workflow.
2026-06
Medtronic Newsroom
Medtronic submits 510(k) filings to expand Hugou2122 robotic-assisted surgery system into general and gynecologic specialties in the United States
Medtronic submitted 510(k) filings to the FDA to expand the use of its Hugou2122 robotic-assisted surgery system into general and gynecologic specialties in the U.S. This expansion follows the system's initial urology indication.
2026-06
Medtronic Newsroom
Medtronic announces strategic investments to support future expansion of cardiac ablation portfolio as physician demand for Afferau2122 technologies broadens
Medtronic announced strategic investments to support the expansion of its cardiac ablation portfolio, driven by increasing physician demand for Afferau2122 technologies. These investments highlight Medtronic's commitment to growth in the cardiac ablation business.
2026-06
Medtronic
Medtronic Surgical Technology Research Grants
Medtronic announced that its surgical technology research grant program will begin accepting applications on June 23, 2026, for novel research to advance surgical science. Grants of up to $50,000 USD will be awarded for the 2027-2028 period.
2026-06
The HIPAA Journal
Medtronic Notifies 3.8M Individuals About April 2026 Cyberattack
Medtronic has begun notifying 3.8 million individuals about a cyberattack in April 2026, for which the ShinyHunters threat group claimed responsibility. While the group alleged theft of over 9 million records, Medtronic has not confirmed this figure or if a ransom was paid.
2026-07
Medtech Insight
FDA Flags Medtronic Harmony Catheter Recall As Class I Over Tip Detachment
The FDA has issued a Class I recall, its most serious designation, for Medtronic's Harmony Delivery Catheter System due to the risk of the distal tip detaching during implantation. This can necessitate additional medical interventions like endovascular retrieval or open-heart surgery.
2026-07
Medtronic
Medtronic and Apollo Hospitals Announce Strategic Partnership to Establish State-of-the-Art Advanced ICU in Hyderabad
Medtronic and Apollo Hospitals have partnered to establish an 11-bed advanced ICU in Hyderabad, featuring integrated acute care and monitoring technologies. This facility will also serve as a clinical innovation hub for Medtronic's R&D.
2026-07

Frequently Asked Questions

Medtronic is a global leader in healthcare technology, offering a wide range of medical devices and therapies for over 70 health conditions. Key areas include cardiac care with pacemakers, defibrillators, and heart failure devices; comprehensive diabetes management solutions such as insulin pumps and continuous glucose monitoring systems; and neurostimulation therapies for chronic pain, Parkinson's disease, bladder/bowel control, and diabetic peripheral neuropathy.
Medtronic is significantly integrating AI into its portfolio for enhanced diagnostics, such as the GI Genius for colonoscopy polyp detection and advanced algorithms in pulse oximeters. In surgical settings, AI powers systems like AiBLE for robotic-assisted surgeries and the Hugo RAS system, while the Touch Surgeryu2122 Ecosystem provides AI-driven surgical video management, analytics, and live streaming for training and performance improvement.
Medtronic offers robust remote monitoring and connected care solutions, including Medtronic Care Management Services (MCMS) for chronic conditions and post-acute recovery. Many of their connected devices, such as cardiac implantable electronic devices and insulin pumps, are compatible with smartphone apps like MyCareLink Heart, enabling real-time data transmission, virtual notifications, and personalized insights for clinicians and patients.
Medtronic prioritizes patient safety and security, implementing a 'security-by-design' approach aligned with global standards like ISO/IEC 27000 and the NIST Cybersecurity Framework. They proactively monitor for vulnerabilities and maintain a coordinated disclosure program, continuously making security improvements across their product lifecycle. While past vulnerabilities, such as in the N'Vision Clinician Programmer, have been addressed with recommendations for strict control, Medtronic emphasizes that the therapeutic benefits of its products outweigh potential security risks.
Medtronic provides extensive support and training through programs like Medtronic Academy, simulator trainings, and fellowship programs, educating healthcare professionals on the safe and effective use of their devices and therapies. They engage in ethical collaborations with physicians for clinical research and the development of patient education materials, ensuring alignment with clinical needs and best practices.
Medtronic's business model is centered on value-based healthcare, aiming to develop products and services that improve clinical and economic outcomes per dollar spent. They focus on creating efficient systems that reduce costs while enhancing patient outcomes and expanding access to quality care. Medtronic also engages in direct negotiations with hospitals to streamline the value chain and potentially lower costs for consumers.
Medtronic is undergoing a strategic transformation to become a more agile, high-tech innovator, with a long-term vision focused on innovation-driven growth. The company is heavily investing in R&D, particularly in high-growth areas like Structural Heart, Surgical Robotics, Neurovascular, Diabetes, and Cardiac Ablation Solutions, and integrating AI and IoT into smart medical solutions. Medtronic anticipates sustained organic revenue growth and demonstrates financial stability through consistent dividend increases.

Related Companies

Google DeepMind is a leading artificial intelligence (AI) research laboratory, a subsidiary of Alphabet Inc., dedicated to developing advanced AI systems to benefit humanity. The company focuses on creating general-purpose AI that can learn and solve complex problems, drawing inspiration from neuroscience and machine learning. Their work spans various fields, including healthcare, scientific discovery, and […]

TalkToMedi is a Canadian healthcare AI company that has developed a clinical-grade voice AI platform called MEDI. This platform is designed to automate patient communication and administrative tasks for medical clinics, including family medicine, specialty clinics, allied health, and physiotherapy. MEDI handles high-volume patient calls, automating appointment inquiries, booking, rescheduling, and cancellations based on the […]

Menaela is an AI-first practice management system designed for solo practitioners, small private clinics, and clinic owners. It integrates patient communication, scheduling, CRM, and medical documentation into a single platform, aiming to replace multiple disconnected tools and bots. The system features an AI practice manager that understands natural-language requests, utilizes real clinic data, and performs […]

Avie is operated by AVIE TECNOLOGIA LTDA, headquartered in Santo André, São Paulo, Brazil. Avie provides WhatsApp reception in Brazilian Portuguese, appointment scheduling, rescheduling and cancellations through Google Calendar or Feegow, clinic CRM, follow-up messages and an online booking website. Clinic staff can review conversations and take over when human support is needed. Clinic CRM […]

Saile is a physician-founded healthcare technology company that addresses critical inefficiencies in healthcare staffing and credentialing. Their AI-powered platform acts as a “universal credential passport” for physicians, centralizing and managing all medical licenses, certifications, and CME credits in one secure, portable vault. This system aims to significantly reduce the administrative burden and delays associated with […]

Data Capture Experts (DCE) is an Australian-based healthcare AI company that is at the forefront of digital health transformation. They specialize in developing and implementing digital health platforms that integrate data, technology, and human-centered design to create intuitive and connected healthcare systems. Their flagship platform, DC2Vue, is designed to go beyond traditional Electronic Medical Records […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.